Quantum Biopharma (QNTM) Shares Outstanding (2019 - 2025)

Quantum Biopharma's (QNTM) quarterly Shares Outstanding came in at $42.0 in Q4 2025, down 41.67% quarter-over-quarter from $72.0 in Q4 2021.

Quantum Biopharma (QNTM) Shares Outstanding (2019 - 2025) Analysis & Trends

Quantum Biopharma has disclosed Shares Outstanding across 4 years of filings, most recently posting $42.0 for Q4 2025.

Shares Outstanding for Q4 2025 came in at $42.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $42.0 (changed N/A YoY), and the FY2025 annual result was $42.0, changed N/A from the prior year.
Shares Outstanding came in at $3.9 million for Q4 2025 at Quantum Biopharma, down from $40.5 million in the prior quarter.
In the past five years, Shares Outstanding ranged from a high of $40.5 million in Q4 2021 to a low of $3.9 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	40.14 Bn
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	91.57 Bn
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-1.88
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	254.16 Mn
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Regeneron Pharmaceuticals	63.43 Bn	54.67 Bn	3.31 Bn	1.80 Mn

Download Data